Taro Drug Patent Portfolio
Taro owns 1 orange book drug protected by 2 US patents Given below is the list of Taro's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7560445 | Process for preparing malathion for pharmaceutical use | 01 Feb, 2027 | Active |
| US7977324 | Process for preparing malathion for pharmaceutical use | 14 Aug, 2026 | Active |
Latest Legal Activities on Taro's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Taro.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 12 Jan, 2023 | US7977324 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Jan, 2021 | US7560445 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 13 Nov, 2018 | US7977324 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 09 Mar, 2017 | US7977324 |
|
Email Notification
Critical
| 09 Mar, 2017 | US7977324 |
|
Correspondence Address Change
Critical
| 07 Mar, 2017 | US7977324 |
|
Email Notification
Critical
| 23 Feb, 2017 | US7560445 (Litigated) |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 23 Feb, 2017 | US7560445 (Litigated) |
|
Correspondence Address Change
Critical
| 21 Feb, 2017 | US7560445 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 04 Sep, 2012 | US7977324 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Jul, 2011 | US7977324 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Jul, 2011 | US7977324 |
|
Email Notification
Critical
| 23 Jun, 2011 | US7977324 |
|
Issue Notification Mailed
Critical
| 22 Jun, 2011 | US7977324 |
| Dispatch to FDC | 16 Jun, 2011 | US7977324 |
Taro's Family Patents
Taro drugs have patent protection in a total of 6 countries. It has a significant patent presence in the US with 58.8% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Taro Drug List
Given below is the complete list of Taro's drugs and the patents protecting them.
1. Ovide
Ovide is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7560445 | Process for preparing malathion for pharmaceutical use |
01 Feb, 2027
(1 year, 4 months from now)
| Active |
| US7977324 | Process for preparing malathion for pharmaceutical use |
14 Aug, 2026
(10 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ovide's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List